PDCD1 and neoplasm: Furthermore, in LUAD, FLT3LG expression was found to impact the penetration of immune cells in the tumor microenvironment and the overall quantity of immune cells, and these findings suggest that FLT3LG expression has the potential to increase the efficacy of anti-PD-1 immunotherapy.